Donate to DS Daily

 

DrugScope membership

DrugScope members work across a broad range of services, interests and professions - all share a commitment to reduce the harms caused by drugs and alcohol.

 

For details about organisation and individual membership visit our website

 

What is happening to services in your area?

Recovery Watch

 
March/April Druglink

Find out more and read a free article - interview with Baroness Molly Meacher

 


 

Advertisements

Contact Jackie Buckle to advertise here:

 

 

Chris Knott Insurance

 

................................

 

Recovery Evolution Festival 2013

 

Recovery Evolution Festival June 2013 - Be Part of the Celebration!

Great Music, Food, Conversation and Meditation

 

................................

 

Harm Reduction conference

 

June 9-12 Vilnius, Lithuania

 

Limited spaces – register now for IHRC2013!

 

Book online to take part in the largest global harm reduction meeting to network, learn and debate current policy and practice.

 

................................

 

Skills Consortium

 

Skills Consortium Conference 2013: Building Effective Practice


28 Jun 2013, Resource for London, N7 6PA

Pricing:
£95 (incl. VAT) for non members
£65 (incl. VAT) for members

 

If you are interested in attending then please email DrugScope

................................

 

Adfam logo

Adfam Annual Conference

Hidden Harm: 10 years on – where next for responses to parental substance use?

Date: 14th June 2013 – London. Length: 1 day
Early bird rate: £98.00 (available until the end of April) 10% discount available on all multiple bookings.

................................

 

ISCE logo

First International Conference on Drugs and Dependence - "Recovery is Possible"

 

Hosted by ISCE in Portugal and the Centre for Drug Misuse Research in Glasgow. Key topics include the drug situation in Portugal, drugs and the media, decriminalisation, and tackling the growth of smart shops...

 


See what people say about DS Daily

 
Comments / sponsorship

If you have any comments about DS Daily or to find out about sponsorship please contact the Editor: Jackie Buckle

 

 

Subscribe to our weekly email

 

DrugScope is pleased to present DS Daily in association with

DDN logo

 

Take a look at the latest jobs...

on the DDN site here

 


Thanks to the following Main sponsors:

 

Action on Addiction logo

 

Arch initiatives

 

Compass

 

Frontier Medical Group

 

NDARC logo

National Drug and Alcohol Research Centre
University of New South Wales

 

Passages logo

Passages Malibu Rehab in USA specializes in non 12-step & non-disease model of addiction treatment..

 

PROMIS logo

 

Westminster Drug Project

 

 

Could you sponsor DS Daily? Please Email
Jackie Buckle to discuss options

 


 

DrugScope supports the Skills Consortium

 

Skills Consortium logo

 


 

Follow DrugScope on Twitter

 

Bookmark and Share

 


Follow developments on DS Daily on our new blog

 

 

 

 

 

 

 

Gold sponsors:

NTA logo
Blenheim CDP
Phoenix Futures logo
Castle Craig
Cri

In association with:

EMCDDA logo

 

DS Weekly - 17th May 2013

Follow DrugScope on Twitter

 

If you only want a summary of the week's news, you can sign up just for that service here.

Home Office tour to study drug policies in 10 countries

Review to include Portugal's limited decriminalisation, Denmark's 'fixing rooms' and Sweden's zero-tolerance approach | Guardian, UK

Amazon halts sale of deadly legal highs after pressure from drugs campaigners

Amazon has pulled from sale two dangerous legal highs after pressure from drugs campaigners. On Saturday, the Mail revealed that salvia – described as more potent than LSD – and amyl nitrate were on sale on Amazon [DrugScope quoted]| Mail Online, UK

Drugs 2.0: The Web Revolution That's Changing How the World Gets High by Mike Power – review

The web has transformed drug use in profound and unsettling ways | Observer, UK

Giving to beggars 'fuels addiction' warns campaign in Manchester

People in Manchester should not to give money to beggars - charities, police and the city council have said | BBC, UK

UK launch for Lundbeck's alcohol dependency drug Selincro

Lundbeck has launched Selincro in the UK, giving patients access to the first new drug for alcohol dependence in more than a decade | PharmaTimes, UK

Biotie puts cocaine dependence drug into Phase II

Following in the footsteps of Selincro, its recently-launched drug to cut alcoholic urges, Biotie Therapies Corp has started a mid-stage study of nepicastat for cocaine dependence | PharmaTimes, UK

Barriers and facilitators to Hepatitis C treatment for people who inject drugs

Through qualitative interviews with HCV treatment providers and people who inject drugs (PWID) this research explores the experience of HCV treatment access and delivery from patient, provider and ‘system’ perspectives... | Skills Consortium, UK

Everyday lives of recovering heroin users

The research draws on the personal accounts of 40 recovering heroin users detailing the psychological, physical and social elements of their unique recovery journeys| Skills Consortium, UK

NIHR call for research proposals in the fields of alcohol and substance misuse in younger people

NIHR has now issued a call for new research on alcohol and substance misuse in younger people, under the NIHR Efficacy and Mechanism Evaluation (EME) Programme. This programme focuses on evaluating the clinical efficacy of an intervention and adding to our understanding of biological and behavioural mechanisms and processes | Medical Research Council, UK

Synthetic cannabis - video

Synthetic cannabis - 93% of tokers don't prefer it! The spray on stone - like fake tans are bad for your health. If it doesn't look like weed, smell like weed or taste like weed then don't smoke it. GDS and Dr John Ramsay discuss synthetic cannabis products and wonder why? | YouTube, UK

'Alcohol and British Society' - Alcohol Research UK - videos

Videos from Alcohol Research UK's 2013 conference took place on 12 March 2013, exploring alcohol and British society have now been uploaded to FEAD | FEAD, UK

The NICE Tobacco Return on Investment Tool

We are currently working to extend the tobacco return on investment tool (for example to include youth prevention) and are developing new return on investment tools for alcohol and physical activity - we aim to publish these 3 developments in the Autumn | NICE, UK

Support don't punish

New website for a global advocacy campaign to raise awareness of the harms that are being caused by the criminalisation of people who use drugs | IDPC, UK

Cannabis linked to prevention of diabetes

Regular users of the drug found to have lower levels of insulin after fasting, research shows | Independent, UK

First set of NICE public health quality standards revealed

Mike Kelly, Director of Public Health at NICE reacts to the announcement that NICE will produce public health quality standards | NICE, UK

Can the therapeutic relationship be *too* good?

Rarely has substance use counselling been so deeply analysed as in this US study. The far-reaching implications are that some counsellors generate more effective relationships with clients which feed through to better outcomes - but also that the ‘best’ relationships are not on average the most effective | Drug and Alcohol Findings, UK

Drugs adviser issues tough warning on 'legal highs'

The Government’s senior drugs adviser has issued a stark warning about the dangers of “legal highs” and admitted there are now 200 potentially dangerous synthetic drugs which have yet to be banned | Telegraph, UK

Police launch mephedrone raids across Great Manchester

Police have raided a suspected crime gang in the biggest operation to date to tackle dealing of party drug mephedrone | Independent, UK

Thousands of 'dangerous' cigarettes on sale in UK

A former shop owner has admitted selling "dangerous" cigarettes, in a landmark case brought by Lincolnshire Trading Standards | BBC, UK

Youngsters use dementia drugs to boost brain power, survey finds

Medicines used for Alzheimer's disease and attention deficit hyperactivity disorder taken by 1% of 14 to 18-year-olds | Guardian, UK